| RS1255627156 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS1255634399 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1255635522 |
NPR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tall stature-scoliosis-macrodactyly of the great toes syndrome, Acromesomelic dysplasia 1 |
| RS1255638075 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 4, Left ventricular noncompaction 10 |
| RS1255667756 |
PCDH12
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1255681916 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1255698056 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS1255699601 |
TUBB4A
|
Health Risk |
Likely pathogenic |
— |
| RS1255727604 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 26, Cardiovascular phenotype |
| RS1255730342 |
SLC39A4
|
Health Risk |
Likely pathogenic |
Hereditary acrodermatitis enteropathica, Hereditary acrodermatitis enteropathica |
| RS1255733467 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1255733657 |
NBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly, normal intelligence and immunodeficiency |
| RS1255742539 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS1255744065 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS1255744452 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1255748366 |
AFG2A
|
Health Risk |
Pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1255750954 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS1255770587 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1255777033 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1255779642 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1255802415 |
SMAD6
|
Health Risk |
Likely pathogenic |
Radioulnar synostosis, Radioulnar synostosis |
| RS1255828000 |
UBR1
|
Health Risk |
Likely pathogenic |
— |
| RS1255836046 |
ETHE1
|
Health Risk |
Pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS1255838105 |
DUOX2
|
Health Risk |
Likely pathogenic |
— |
| RS1255840091 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS1255841566 |
PAX1
|
Health Risk |
Pathogenic |
— |
| RS1255849432 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
FG syndrome, FG syndrome |
| RS1255855620 |
ZEB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mowat-Wilson syndrome, Inborn genetic diseases |
| RS1255892076 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1255903649 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1255908000 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS1255911887 |
GCK
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS1255916068 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1255919164 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS1255940179 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1255952340 |
CTSK
|
Health Risk |
Likely pathogenic |
— |
| RS1255961940 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1255988475 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS1255988597 |
CASQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1256028809 |
RTTN
|
Health Risk |
Pathogenic |
Microcephalic primordial dwarfism due to RTTN deficiency, Microcephalic primordial dwarfism due to RTTN deficiency |
| RS1256029497 |
ARPC1B
|
Health Risk |
Pathogenic |
Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease, Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease |
| RS1256036525 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hereditary spastic paraplegia 11 |
| RS1256037063 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS1256047792 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1256049181 |
DRD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary attention deficit-hyperactivity disorder, Hereditary attention deficit-hyperactivity disorder |
| RS1256078127 |
AP4B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 47, Hereditary spastic paraplegia |
| RS1256082707 |
VWF
|
Health Risk |
Likely pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS1256092775 |
OSTM1
|
Health Risk |
Pathogenic |
— |
| RS1256094664 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS1256103643 |
MC2R
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1256144022 |
RARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS1256152851 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1256155089 |
KCNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS1256164950 |
CERS3
|
Health Risk |
Likely pathogenic |
Abnormality of the skin, Abnormality of the skin |
| RS1256178504 |
ACAD9
|
Health Risk |
Pathogenic/Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS12562058 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS1256212335 |
CHST14
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, musculocontractural type |
| RS1256215388 |
LRSAM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS1256250558 |
GPAA1
|
Health Risk |
Likely pathogenic |
— |
| RS1256250716 |
SLC38A8
|
Health Risk |
Pathogenic |
— |
| RS1256260277 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS1256311452 |
HFE
|
Health Risk |
Pathogenic |
Hereditary hemochromatosis, Hereditary hemochromatosis |
| RS1256337877 |
NAGS
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperammonemia, type III |
| RS1256347636 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to partial LAMA2 deficiency, LAMA2-related muscular dystrophy |
| RS1256347904 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1256349457 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1256350761 |
ZNF292
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder, autosomal dominant 64 |
| RS1256371424 |
PHKA1
|
Health Risk |
Pathogenic |
Glycogen storage disease IXd, Glycogen phosphorylase kinase deficiency |
| RS1256376226 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 1A (Zellweger), Zellweger spectrum disorders |
| RS1256402686 |
NEXMIF
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked intellectual disability, Cantagrel type |
| RS1256417163 |
ZNF292
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1256418853 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hyperinsulinism, Maturity-onset diabetes of the young |
| RS1256419231 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, Sialuria |
| RS1256470015 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1256482040 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1256482530 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1256488073 |
MRPL3
|
Health Risk |
Likely pathogenic |
Neonatal encephalopathy, Neonatal encephalopathy |
| RS1256505387 |
COL4A3
|
Health Risk |
Likely pathogenic |
Alport syndrome, COL4A3-related disorder |
| RS1256507861 |
ALOX12B
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 2, Autosomal recessive congenital ichthyosis 2 |
| RS1256541161 |
EFTUD2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1256580853 |
CYP11B1
|
Health Risk |
Pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Glucocorticoid-remediable aldosteronism |
| RS1256610157 |
MED13
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1256621322 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, POLE-related disorder |
| RS1256629719 |
KIF14
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 20, primary |
| RS1256695300 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 26 |
| RS1256710740 |
RAD50
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1256710897 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Congenital contractural arachnodactyly |
| RS1256727206 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1256735931 |
IDUA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1256753725 |
PJVK
|
Health Risk |
Pathogenic |
— |
| RS1256773607 |
PIGW
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 5, Hyperphosphatasia with intellectual disability syndrome 5 |
| RS1256778304 |
MYOF
|
Health Risk |
Pathogenic |
Angioedema, hereditary |
| RS1256783641 |
SIK1
|
Health Risk |
Likely pathogenic |
Global developmental delay, Language disorder |
| RS1256819927 |
PTS
|
Health Risk |
Pathogenic |
6-Pyruvoyl-tetrahydrobiopterin synthase deficiency, Nonpapillary renal cell carcinoma |
| RS1256848235 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1256856876 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS1256865383 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1256882753 |
ASS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia type I, Citrullinemia |
| RS12568913 |
NPHS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS1256894448 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |